For: | Ju YC, Jun DW, Choi J, Saeed WK, Lee HY, Oh HW. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis. World J Gastroenterol 2018; 24(40): 4606-4614 [PMID: 30386110 DOI: 10.3748/wjg.v24.i40.4606] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i40/4606.htm |
Number | Citing Articles |
1 |
Han Wu, Hao Xing, Lei Liang, Bin Huang, Chao Li, Wan Yee Lau, Ya-Hao Zhou, Wei-Min Gu, Hong Wang, Ting-Hao Chen, Yao-Ming Zhang, Yong-Yi Zeng, Timothy M. Pawlik, Ming-Da Wang, Meng-Chao Wu, Feng Shen, Tian Yang. Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study. European Journal of Surgical Oncology 2019; 45(12): 2360 doi: 10.1016/j.ejso.2019.09.009
|
2 |
Lung-Yi Mak, Man-Fung Yuen. Hepatitis B Virus and Liver Disease. 2021; : 455 doi: 10.1007/978-981-16-3615-8_19
|
3 |
Giacomo Zaccherini, Manuel Tufoni, Mauro Bernardi, Paolo Caraceni. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents. Journal of Clinical Medicine 2021; 10(19): 4590 doi: 10.3390/jcm10194590
|
4 |
Yusuf Emre Ozdemir, Meryem Sahin Ozdemir, Osman Faruk Bayramlar, Serkan Surme, Sibel Yildiz Kaya, Ridvan Karaali, Ilker Inanc Balkan, Bilgul Mete, Nese Saltoglu, Fehmi Tabak. Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B. Irish Journal of Medical Science (1971 -) 2023; 192(2): 633 doi: 10.1007/s11845-022-03066-y
|
5 |
Sung Hwan Yoo, Tae Seop Lim, Hyun Woong Lee, Ja Kyung Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jung Il Lee, Kwan Sik Lee, Seung Up Kim. Risk assessment of hepatocellular carcinoma and liver‐related events using ultrasonography and transient elastography in patients with chronic hepatitis B. Journal of Viral Hepatitis 2021; 28(10): 1362 doi: 10.1111/jvh.13560
|
6 |
Tae Hyung Kim, Soon Ho Um, Young‐Sun Lee, Sun Young Yim, Young Kul Jung, Yeon Seok Seo, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun. Determinants of re‐compensation in patients with hepatitis B virus‐related decompensated cirrhosis starting antiviral therapy. Alimentary Pharmacology & Therapeutics 2022; 55(1): 83 doi: 10.1111/apt.16658
|
7 |
Xinxin Rong, Guangde Yang, Yuanyuan Xu, He Chen, Xia Wang, Juanjuan Fu, Li Li, Xiucheng Pan. Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First‐Time HBV‐Related Decompensated Cirrhosis. Journal of Viral Hepatitis 2024; doi: 10.1111/jvh.14029
|
8 |
Zhaobo Liu, Min Wu, Dongdong Lin, Ning Li. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma. Journal of International Medical Research 2020; 48(2) doi: 10.1177/0300060520902575
|
9 |
Shifei Wen, Jiajia Ruan, Jiaming Shen, Xia Wang, Guangde Yang, Juanjuan Fu, Li Li, Xiucheng Pan. Development and validation of a nomogram to predict recompensation in HBV-related cirrhosis with ascites as the single first decompensating event. Scandinavian Journal of Gastroenterology 2023; 58(8): 915 doi: 10.1080/00365521.2023.2181037
|
10 |
Zhiying He, Jialing Zhou, Yu Tian, Shanshan Wu, Yameng Sun, Xiaojuan Ou, Jidong Jia, Bingqiong Wang, Xiaoning Wu, Hong You. Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis. Scandinavian Journal of Gastroenterology 2023; 58(4): 403 doi: 10.1080/00365521.2022.2132532
|
11 |
Hailemichael Desalegn, Stian Magnus Staurung Orlien, Hanna Aberra, Eyerusalem Mamo, Sine Grude, Kristina Hommersand, Nega Berhe, Svein Gunnar Gundersen, Asgeir Johannessen. Five-year results of a treatment program for chronic hepatitis B in Ethiopia. BMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-03082-4
|